Johnson & Johnson (J&J) has announced that a US Food and Drug Administration (FDA) panel of experts has recommended Darzalex ...

This sounds entirely obvious but failure to translate this insight into more innovative patient support contributes to the ...

Merck & Co – known as MSD outside the US and Canada – has shared promising results from a late-stage study of its anti-PD-1 ...

Results presented at this year’s American Thoracic Society International Conference showed that the trials met their primary ...

Join us on an adventure Alex Legg is one of 15 speakers at Adventures In Pharma on 1 July in London. Join him there to ...

Bristol Myers Squibb (BMS) has announced that its PD-1 immune checkpoint inhibitor Opdivo (nivolumab) has been approved by ...

Eli Lilly has unveiled plans to expand its long-standing partnership with Purdue University, with the drugmaker investing up ...

The US Food and Drug Administration (FDA) has approved Fujirebio Diagnostics’ Alzheimer’s disease (AD) blood test to help ...

Regeneron Pharmaceuticals has announced that it will be acquiring human genetics and biotechnology company 23andMe for $256m.

Science communication, together with creativity, ensures that information is both accurate and accessible. In order to ...

AbbVie’s Emrelis (telisotuzumab vedotin-tllv) has been granted accelerated approval by the US Food and Drug Administration ...

MSD – known as Merck & Co in the US and Canada – has received approval from the Medicines and Healthcare products Regulatory ...